Gilead Sciences President John Milligan Interview

John Milligan, president and chief operating officer of Gilead Sciences Inc., speaks during an interview in New York, U.S., on Tuesday, Feb. 11, 2014. Gilead Sciences Inc., the world's largest maker of HIV medicines, received U.S. approval in December for Sovaldi, the treatment for hepatitis C it acquired in its $11 billion purchase of Pharmasset Inc. in 2012. Photographer: Victor J. Blue/Bloomberg via Getty Images
John Milligan, president and chief operating officer of Gilead Sciences Inc., speaks during an interview in New York, U.S., on Tuesday, Feb. 11, 2014. Gilead Sciences Inc., the world's largest maker of HIV medicines, received U.S. approval in December for Sovaldi, the treatment for hepatitis C it acquired in its $11 billion purchase of Pharmasset Inc. in 2012. Photographer: Victor J. Blue/Bloomberg via Getty Images
Gilead Sciences President John Milligan Interview
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
468720965
Collection:
Bloomberg
Date created:
February 11, 2014
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
GILEAD MILLIGAN